Go to the For patients section
Go to the For entrepreneurs section
Go to the Public information section
Go to the Footer section
Log in to the panel
My Gov
Home
Council of Ministers
The Chancellery of the Prime Minister
Ministries
Offices, institutions and offices of the RP
Services for citizens
Services for business
Services for officials
Services for farmers
Trusted profile
Knowledge base
Civil service
Сайт для громадян України – Service for Ukrainian citizens
Close the GOV.pl menu
gov.pl
gov.pl
Website of the Republic of Poland
go to search
Log in to the panel
My Gov
Change language
EN
PL - polski
Chief Pharmaceutical Inspectorate
MENU
About us
About us
Tasks of the State Pharmaceutical Inspection
The competence of the Chief Pharmaceutical Inspector
Departments
Counteracting corruption
Personal Data Protection
Asset Information
What we do
What we do
International cooperation
Serialisation of medicinal products
Quality supervision
Medicinal product advertising
Falsified medicinal products
Certificate of Good Manufacturing Practice - inspection in a third country
Our services
Our services
Information for patiens
Information for entrepreneurs
Types of services
Contact
Contact
Contact us
Bank account
Contact for media
Information for persons with disabilities
News
News
Pharma Supply 2025 - About the Challenges of Good Distribution Practice
Oncological Prevention in Autumn at CPI
Celebration of National Pharmacist Day
25th anniversary of the Central Bureau of Investigation of the Police with the participation of the Chief Pharmaceutical Inspector
Summary of healthcare activities under the Polish Presidency
GIF representatives in the Polish Parliament on the role of the pharmacist
Director of the Chief Pharmaceutical Inspector's Office discusses reimbursement law reform and a new drug availability category
Joint announcement of the Chief Pharmaceutical Inspector, the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products and the Chief Sanitary Inspector regarding the suspension of the sale of a series of the chickenpox vaccine (Varilrix No. A70CD868B)
Contribution of the Chief Pharmaceutical Inspectorate experts to the success of the pharmaceutical package EU negotiations
What is the difference between a suspension and a withdrawal of a medicinal product?
Polish Pharmaceutical Inspection hosted international WGEO experts meeting
Health committee meeting "Challenges for health security in the European Union”
Chief Pharmaceutical Inspectorate warns - drugs and alcohol are dangerous
Ukrainian prescriptions - Set of rules for issuing prescriptions in Ukraine
Award for 'Fighting discrimination against people with disabilities'
The Patient Rights Ombudsman and the Chief Pharmaceutical Inspector together for the safety of Polish patients
Don't rob yourself of your health! Fake medicines are a real threat
Change language
EN
PL - POLSKI
Close the menu
The mission of the Chief Pharmaceutical Inspector is ensuring the safety of patients by supervising and controlling the manufacture and marketing of medicinal products.
Register of decisions
Find out more
Controlled substances
Find out more
International cooperation
Find out more
For patients
See all
Withholding and recall of medicinal products
Returning medicines to a pharmacy
Illicit drugs - how to avoid them?
Falsified medicines
Online medicines sale
Places of falsified medicines distribution
For entrepreneurs
See all
Export or sale outside the Republic of Poland
Order refusal copies
Reporting the list of transport means
Controlled substances
Types of licences issued
Types of decisions issued
Public information
See all
Complaints and requests
Petitions
Access to public information
Honorary patronage
Lobbying
{"register":{"columns":[]}}